These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 30345488)
1. Changes in Hemoglobin Concentrations Post-immunoglobulin Therapy in Patients with Kawasaki Disease: A Population-Based Study Using a Claims Database in Japan. Takeuchi M; Ito S; Nakamura M; Kawakami K Paediatr Drugs; 2018 Dec; 20(6):585-591. PubMed ID: 30345488 [TBL] [Abstract][Full Text] [Related]
2. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease. Kuo HC; Lo MH; Hsieh KS; Guo MM; Huang YH PLoS One; 2015; 10(12):e0144603. PubMed ID: 26658843 [TBL] [Abstract][Full Text] [Related]
3. High-dose intravenous immunoglobulin is strongly associated with hemolytic anemia in patients with Kawasaki disease. Nolan BE; Wang Y; Pary PP; Luban NLC; Wong ECC; Ronis T Transfusion; 2018 Nov; 58(11):2564-2571. PubMed ID: 30265742 [TBL] [Abstract][Full Text] [Related]
4. Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan. Uehara R; Belay ED; Maddox RA; Holman RC; Nakamura Y; Yashiro M; Oki I; Ogino H; Schonberger LB; Yanagawa H Pediatr Infect Dis J; 2008 Feb; 27(2):155-60. PubMed ID: 18174868 [TBL] [Abstract][Full Text] [Related]
5. Hepcidin-Induced Iron Deficiency Is Related to Transient Anemia and Hypoferremia in Kawasaki Disease Patients. Huang YH; Kuo HC; Huang FC; Yu HR; Hsieh KS; Yang YL; Sheen JM; Li SC; Kuo HC Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187366 [TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin G values before treatment are correlated with the responsiveness to initial intravenous immunoglobulin therapy for Kawasaki disease. Yanagimoto K; Nomura Y; Masuda K; Hirabayashi M; Morita Y; Yoshishige M; Ueno K; Eguchi T; Kawano Y Int Arch Allergy Immunol; 2014; 164(2):83-8. PubMed ID: 24903098 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the laboratory data between Kawasaki disease and enterovirus after intravenous immunoglobulin treatment. Lin LY; Yang TH; Lin YJ; Yu HR; Yang KD; Huang YC; Chang WC; Kuo HC Pediatr Cardiol; 2012 Dec; 33(8):1269-74. PubMed ID: 22447381 [TBL] [Abstract][Full Text] [Related]
9. Relationship between post-IVIG IgG levels and clinical outcomes in Kawasaki disease patients: new insight into the mechanism of action of IVIG. Goto R; Inuzuka R; Shindo T; Namai Y; Oda Y; Harita Y; Oka A Clin Rheumatol; 2020 Dec; 39(12):3747-3755. PubMed ID: 32458247 [TBL] [Abstract][Full Text] [Related]
10. Intravenous immunoglobulin-related hemolysis in patients treated for Kawasaki disease. Luban NL; Wong EC; Henrich Lobo R; Pary P; Duke S Transfusion; 2015 Jul; 55 Suppl 2():S90-4. PubMed ID: 26174904 [TBL] [Abstract][Full Text] [Related]
11. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease. Tse SM; Silverman ED; McCrindle BW; Yeung RS J Pediatr; 2002 Apr; 140(4):450-5. PubMed ID: 12006960 [TBL] [Abstract][Full Text] [Related]
12. Inflammation-induced hepcidin is associated with the development of anemia and coronary artery lesions in Kawasaki disease. Kuo HC; Yang YL; Chuang JH; Tiao MM; Yu HR; Huang LT; Yang KD; Chang WC; Lee CP; Huang YH J Clin Immunol; 2012 Aug; 32(4):746-52. PubMed ID: 22392047 [TBL] [Abstract][Full Text] [Related]
13. Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease. Kuo HC; Liang CD; Wang CL; Yu HR; Hwang KP; Yang KD Acta Paediatr; 2010 Oct; 99(10):1578-83. PubMed ID: 20491705 [TBL] [Abstract][Full Text] [Related]
14. [Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study]. Qin LJ; Wang HW; Hu XF; Liu QJ; Shi H; Wei YX; Chen QJ; Cheng PX Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):891-5. PubMed ID: 17254453 [TBL] [Abstract][Full Text] [Related]
15. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status. Qiu H; He Y; Rong X; Ren Y; Pan L; Chu M; Wu R; Shi H Postgrad Med; 2018 May; 130(4):442-447. PubMed ID: 29745742 [TBL] [Abstract][Full Text] [Related]
16. TNF-α is superior to conventional inflammatory mediators in forecasting IVIG nonresponse and coronary arteritis in Chinese children with Kawasaki disease. Hu P; Jiang GM; Wu Y; Huang BY; Liu SY; Zhang DD; Xu Y; Wu YF; Xia X; Wei W; Hu B Clin Chim Acta; 2017 Aug; 471():76-80. PubMed ID: 28526535 [TBL] [Abstract][Full Text] [Related]
17. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients. Sato S; Kawashima H; Kashiwagi Y; Hoshika A Int J Rheum Dis; 2013 Apr; 16(2):168-72. PubMed ID: 23773640 [TBL] [Abstract][Full Text] [Related]
18. Intravenous immunoglobulin treatment responsiveness depends on the degree of CD8+ T cell activation in Kawasaki disease. Ye Q; Gong FQ; Shang SQ; Hu J Clin Immunol; 2016 Oct; 171():25-31. PubMed ID: 27519954 [TBL] [Abstract][Full Text] [Related]
19. Predictors of intravenous immunoglobulin resistance and coronary artery aneurysm in patients with Kawasaki disease. Chantasiriwan N; Silvilairat S; Makonkawkeyoon K; Pongprot Y; Sittiwangkul R Paediatr Int Child Health; 2018 Aug; 38(3):209-212. PubMed ID: 29768976 [TBL] [Abstract][Full Text] [Related]
20. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease. Xie T; Wang Y; Fu S; Wang W; Xie C; Zhang Y; Gong F Pediatr Rheumatol Online J; 2017 Mar; 15(1):17. PubMed ID: 28320400 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]